Exchange: OTC·Updated 09:32 AM EDT

ERYFFErytech Pharma - Ordinary Share

$0.0001
$0.0001
(0.00%)
Today
Mkt Cap$1.01M
Vol150.00

About

PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections. The firm develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to combat bacterial infections in humans, particularly those resistant to antibiotics. The company was founded in 2004 and is headquartered in Lyon, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of PHAXIAM Therapeutics S.A. - Ordinary Share?
What is the 52-week high for PHAXIAM Therapeutics S.A. - Ordinary Share?
What is the 52-week low for PHAXIAM Therapeutics S.A. - Ordinary Share?
What is PHAXIAM Therapeutics S.A. - Ordinary Share stock price today?
What is the 50-day moving average of PHAXIAM Therapeutics S.A. - Ordinary Share?

Latest ERYFF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.